IMD is a serious bacterial infection caused by the N. meningitidis bacteria, which can lead to dangerous and sometimes fatal diseases including meningitis (inflammation of the lining of the brain and spinal cord), and sepsis (blood poisoning). Learn more about IMD here
Symptoms of IMD could include sudden fever, drowsiness, irritability or agitation, intense headache, nausea and vomiting, stiff neck, and/or light sensitivity.
IMD could have serious consequences including death, coma, or long-term health problems (in up to 1 in 3 survivors) such as: hearing loss, neurologic disabilities, digit or limb amputations.
A serious infection that can be spread through common adolescent and young-adult behaviours such as close, direct contact, kissing, sharing cups, drinks, and utensils, and close-quartered living.
MenB, caused by N. meningitidis serogroup B bacteria, was associated with >60% of cases of IMD in Canadian adolescents and young adults between 2012 and 2016*
It is the most common cause of IMD in adolescents and young adults in Canada. Learn more about MenB here
You can assess your risk for MenB being completing this questionnaire
TRUMENBA is a vaccine to help prevent MenB (IMD caused by N. meningitidis serogroup B bacteria), for use in individuals aged 10 through 25 years.
NACI recommends that TRUMENBA may be considered as an option for individuals 10–25 years of age who are not at higher risk of meningococcal disease than the general population to reduce the risk of invasive serogroup B meningococcal disease. Learn more about TRUMENBA here
TRUMENBA should not be used if you or your child are allergic to the active substance or any other ingredient in the vaccine.
The usual does is two injections given 6 months apart. If you or your child are at an increased risk of invasive meningococcal disease (IMD) you will be given 3 doses of the vaccine. The second dose will be given 1 month after your initial dose. The third dose will be given at least 4 months after the second dose. Looking for a second dose reminder? Sign up here
If you forget to go back for your/your child’s second dose, ask your doctor for advice.
TRUMENBA can be given at the same time, albeit in different syringes and at separate injection sites, with the following vaccines: quadrivalent human papillomavirus vaccine (HPV4), meningococcal serogroups A,C,W, Y conjugate vaccine (MenACWY) and tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed (Tdap).
Like all vaccines, TRUMENBA can cause side effects, although not everybody gets them. The most common side effects (reported in more than 1 in 10 people) after having TRUMENBA include headache, nausea, diarrhea, muscle pain, joint pain, redness, swelling and pain at the injection site, chills and fatigue (tiredness). Other common side effects (in more than 1 in 100 people) after having TRUMENBA are vomiting and fever ≥38°C.
Find out where the closest vaccination clinics are located by entering your postal code:
Check out additional resources by clicking here